SOURCE: Genmed Holding Corp.

Genmed Holding Corp.

May 25, 2011 09:00 ET

Genmed Announces Approval of Package Size Variation for French Market

AMSTERDAM, THE NETHERLANDS--(Marketwire - May 25, 2011) - Genmed Holding Corp. (OTCBB: GENM) has announced that it received approval from the French Government for their new package size variation, Paracetamol 500 mg 16 tablets. Prior to the approval Genmed was already approved to distribute 20 and 30 tablet package sizes under their seven European Union country distribution license. The 16-tablet package size variation is mandatory for the over-the-counter market in France and opens the door for Genmed's French distribution strategy.

Genmed Chief Executive Officer, Erwin Bouwens, commented on the Company's announcement by saying, "This is a breakthrough step, as it opens up the French over-the-counter market for us. For some time now, we have been having discussions with potential customers in France and we remain optimistic that we can announce our first French distribution deal within weeks."

About Genmed Holding Corp.

Genmed Holding Corp. is a fully reporting publicly traded company that trades on the OTC Bulletin Board under the symbol GENM. It is a United States and Dutch based company focusing on the delivery of low cost generic pharmaceutical drugs directly to distribution channels throughout the world. The Company began its generic drug business in 2008 and today operates primarily through its 100% owned subsidiary Genmed B.V., which is registered in the Netherlands. The Company is led by an experienced management team and board who have considerable and highly relevant experience in product development, registration, sales, marketing, distribution, operations, and financial administration.

For Additional Information, Go to the Website:

This press release contains certain "forward-looking statements" within the meaning of federal securities laws including the use of the words "expect," "anticipate," "estimate," "project," "forecast," "outlook," "target," "objective," "plan," "goal," "pursue," "on track," and similar expressions. Although the Company believes that the statements were reasonable when made, these forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause actual results, performance, or achievements of the company to be different from those expressed or implied. The Company assumes no obligation and does not intend to update these forward-looking statements. Among the important factors that could cause actual results to differ materially from those indicated by such forward-looking statements include, without limitation: competitive and general economic conditions, adverse effects of litigation, the timely development and acceptance of our products and services, significant changes in the competitive environment, the failure to generate or the loss of significant numbers of customers, the loss of senior management or increased government regulation.